Krishna Institute of Medical Sciences Limited (NSE:KIMS)
India · Delayed Price · Currency is INR | Market Cap | 290.50B +8.3% |
| Revenue (ttm) | 45.96B +35.1% |
| Net Income | 2.12B -36.8% |
| EPS | 5.23 -37.8% |
| Shares Out | 400.14M |
| PE Ratio | 138.89 |
| Forward PE | 68.06 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 540,004 |
| Open | 726.15 |
| Previous Close | 726.15 |
| Day's Range | 717.05 - 730.35 |
| 52-Week Range | 575.80 - 858.00 |
| Beta | 0.33 |
| Analysts | Strong Buy |
| Price Target | 863.94 (+19.0%) |
| Earnings Date | Nov 4, 2026 |
About NSE:KIMS
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, ... [Read more]
Financial Performance
In fiscal year 2026, NSE:KIMS's revenue was 39.05 billion, an increase of 28.65% compared to the previous year's 30.35 billion. Earnings were 2.41 billion, a decrease of -37.22%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for KIMS stock is "Strong Buy." The 12-month stock price target is ₹863.94, which is an increase of 19.00% from the latest price.
News
Krishna Institute of Medical Sciences Transcript: Q2 26/27
Q2 revenue and EBITDA grew strongly, while new hospitals and oncology programs weighed on margins. Management expects margins to rise from Q2, with Q4 break-even targeted for Electronic City; expansion and acquisition spending continues.
Krishna Institute of Medical Sciences Quarterly report: Q2 2027
Krishna Institute of Medical Sciences has published its Q2 2027 quarterly earnings report on November 4, 2026.
Krishna Institute of Medical Sciences Slides: Q2 2027
Krishna Institute of Medical Sciences has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on November 4, 2026.
Krishna Institute of Medical Sciences Transcript: Q1 26/27
Revenue grew 36% year-on-year to INR 1,196 crore, with EBITDA up 20% and strong operational growth across clusters. Debt was significantly reduced via QIP, and new units are ramping up well, with Kerala and Bengaluru expected to improve margins over the next few years.
Krishna Institute of Medical Sciences Quarterly report: Q1 2027
Krishna Institute of Medical Sciences has published its Q1 2027 quarterly earnings report on August 4, 2026.
Krishna Institute of Medical Sciences Slides: Q1 2027
Krishna Institute of Medical Sciences has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 4, 2026.
Krishna Institute of Medical Sciences Transcript: Q4 25/26
Revenue grew 35% year-over-year in Q4 FY26, but EBITDA margin declined due to new unit ramp-up and insurance empanelment delays. Mature units maintained strong margins, while new units are expected to turn EBITDA positive within a year. Debt reduction and continued expansion in core markets are planned.
Krishna Institute of Medical Sciences Quarterly report: Q4 2026
Krishna Institute of Medical Sciences has published its Q4 2026 quarterly earnings report on May 18, 2026.
Krishna Institute of Medical Sciences Slides: Q4 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.
Krishna Institute of Medical Sciences Annual report: Q4 2026
Krishna Institute of Medical Sciences has published its Q4 2026 annual report on May 18, 2026.
Krishna Institute of Medical Sciences Transcript: Q3 25/26
Q3 FY 2026 saw record revenue growth of 29.2% YoY, surpassing INR 1,000 crore, despite EBITDA margin compression due to new unit ramp-ups. New hospitals are stabilizing, with break-even targeted in FY 2027, and debt levels expected to moderate as expansion slows.
Krishna Institute of Medical Sciences Quarterly report: Q3 2026
Krishna Institute of Medical Sciences has published its Q3 2026 quarterly earnings report on February 8, 2026.
Krishna Institute of Medical Sciences Slides: Q3 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 8, 2026.
Krishna Institute of Medical Sciences Transcript: Q2 25/26
Revenue grew 23% year-over-year, but EBITDA and margins declined due to ramp-up costs from new hospitals. Management expects margin expansion as new units reach break-even, with ARPOB and specialty mix set to improve. Andhra Pradesh and Telangana clusters remain strong.
Krishna Institute of Medical Sciences Quarterly report: Q2 2026
Krishna Institute of Medical Sciences has published its Q2 2026 quarterly earnings report on November 9, 2025.
Krishna Institute of Medical Sciences Slides: Q2 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 9, 2025.